Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-11 | New | $89,999,975 | $89,999,975 | Equity Only | 06b | SEC link |
| 2023-10-02 | New | $24,474,387 | $24,474,387 | Equity Only | 06b | SEC link |
| 2020-12-23 | New | $27,499,973 | $27,499,973 | Equity Only | 06b | SEC link |
| 2020-05-08 | New | $4,074,989 | $4,074,989 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Shannon Boye | Director |
| Sanford Boye | Executive |
| Chris Carpenter | Director |
| Michael Dial | Director |
| Jacqueline Grant | Director |
| James Healy | Director |
| Christina Isacson | Director |
| Elizabeth Leiderman | Executive |
| Norbert Riedel | Director |
| Patrick Ritschel | Director, Executive |
| Jennifer Wellman | Director |
| Benjamin Yerxa | Director |
| Joe Zakrzewski | Director |